Rock Springs Capital Management LP 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:51 pm Purchase | 2022-12-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Rock Springs Capital Management LP | 136,556 5.550% | 136,556 (New Position) | Filing |